Why are peptides trending?

In recent years, especially now, peptides have come to occupy a central place in conversations about weight loss, longevity and performance. They have ceased to be merely tools of classical endocrinology and have begun to be promoted as near-universal solutions.

But before accepting this idea, it is necessary to understand what is really behind this movement.

Peptides are small chains of amino acids that act as signallers in the body. In other words, they help to "guide" body functions, such as hunger, metabolism, inflammation and regeneration.

This mechanism explains why they are so promising but also why they can be easily overestimated.

The real benefits: where science supports their use

The main breakthrough is in peptides focused on metabolism, especially GLP-1 analogues, such as Semaglutide and Tirzepatide.

These medications have brought a concrete change in medical practice:

  • Significant reduction in body weight

  • More effective blood sugar control

  • Decreased cardiovascular risk in selected patients

  • Increased satiety with direct impact on eating behaviour

Here there is an important point: this is not a trend, but consolidated evidence-based medicine.

Furthermore, other peptides are being studied with potential in:

  • tissue regeneration

  • wound healing

  • improvement of metabolic parameters

However, these uses are still in less robust phases of scientific validation.

The harms and risks: the little-discussed side

The problem is not with peptides themselves, but with how they are being used. Today, there is a clear growth in their use:

  • without formal indication

  • for purely aesthetic purposes

  • without adequate monitoring

And this brings relevant risks.

1. Clinical adverse effects

In metabolic peptides, the most common include:

  • nausea and vomiting

  • constipation

  • muscle mass loss associated with rapid weight loss

In some cases, there is concern about:

  • pancreatitis

  • more persistent gastrointestinal alterations

2. Indiscriminate use and medicalisation

There is a growing trend of transforming mild overweight, aesthetic dissatisfaction or pursuit of performance into a medication indication. This can lead to treatment dependence, loss of metabolic autonomy, neglect of fundamental habits (diet, sleep, exercise).

3. Poorly regulated market (especially outside the metabolic field)

Peptides such as:

  • BPC-157

  • TB-500

have been widely promoted with promises of:

  • accelerated regeneration

  • improvement of physical performance

However, the critical point is clear: there is a lack of robust studies in humans that support these uses safely. In other words, in this scenario, the risk is not only biological, it is also scientific.

The biggest current mistake: treating everything as if it were the same

Today, there is a dangerous mix between:

  • therapies with solid evidence

  • promising therapies still under study

  • and interventions driven by marketing

Putting everything on the same level creates confusion, both for patients and for professionals.

My opinion as a physician

Peptides do represent, indeed, one of the most interesting advances in modern medicine, especially in the treatment of obesity and metabolic diseases. But current enthusiasm needs to be balanced with responsibility. What is observed today is not just innovation.

It is also:

  • aesthetic pressure

  • search for quick solutions

  • and a market that grows faster than the evidence

Peptides do not replace lifestyle. They do not correct, on their own, a disorganised metabolism. And they are definitely not risk-free.

Peptides have real potential, but they are not a universal solution.

Conscious use requires three pillars:

  • correct indication

  • solid scientific basis

  • adequate medical monitoring

Outside of this, what appears to be an advance can, in practice, become just another excess of modern medicine.

Practical summary

  • Peptides are signalling molecules with metabolic and regenerative functions

  • Some, such as GLP-1 analogues, have strong scientific evidence

  • Others still lack robust clinical validation

  • Indiscriminate use can bring risks and frustrations

  • They do not replace healthy lifestyle habits

Dr Rebeca Soares Andrade CRM-GO 39335